Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Treasury Shares (2019 - 2025)

Pulmonx (LUNG) has disclosed Treasury Shares for 7 consecutive years, with $3.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares rose 459.94% to $3.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.7 million, a 459.94% increase, with the full-year FY2023 number at $2.2 million, up 124.83% from a year prior.
  • Treasury Shares was $3.7 million for Q3 2025 at Pulmonx, down from $4.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $4.3 million in Q1 2025 to a low of $106.0 in Q2 2023.
  • A 5-year average of $1.7 million and a median of $998077.0 in 2022 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 941108.49% in 2024; the steepest drop was 72.27% in 2024.
  • Pulmonx's Treasury Shares stood at $442428.0 in 2021, then skyrocketed by 125.68% to $998473.0 in 2022, then skyrocketed by 124.83% to $2.2 million in 2023, then tumbled by 70.31% to $666525.0 in 2024, then skyrocketed by 459.94% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Treasury Shares are $3.7 million (Q3 2025), $4.1 million (Q2 2025), and $4.3 million (Q1 2025).